Danning Tablets In The Treatment Of Non-alcoholic Fatty Liver Safety And Effectiveness Of Clinical Studies (liver Qi Stagnation, Damp Card),

Non-alcoholic fatty liver (NAFLD) refers to the exception of alcohol and other specific factors that caused liver damage to liver cells diffuse bullous fat into the main features of the clinicopathologic syndrome, including simple fatty liver, as well as its the evolution of steatohepatitis (NAFLD) and cirrhosis, insulin resistance and its incidence is closely related genetic susceptibility. With lifestyle and dietary changes in the structure, NAFLD incidence rising incidence trend of younger age, and some patients may progress to end-stage liver disease, which is increasingly concerned about the medical profession. In recent epidemiological survey of non-alcoholic fatty liver high incidence of non-alcoholic fatty liver disease can affect people of different ages, general adult fatty liver detection rate of 10% -20%. To B-as a diagnostic tool of the general population the incidence rate of 5 486 cases reported in Japan (3 889 male, female 1 579), the male incidence of fatty liver are 13.6 percent, 6.8 percent are women, a University in Shanghai 1 600 physical examination, the male 8.8%, 3.8% for females. Another group to CT for diagnostic means 1425 cases of adults, the incidence of fatty liver was 9.7%. To liver biopsy for diagnostic means, and more generally the incidence of thin crowd are 2%, but the crowd than the obesity rate was 19% [2,3]. NAFLD can also affect children, their incidence of 2.6%, but in the more obese children in the incidence rate of 22.5% -52.8% [6]. At present, non-alcoholic fatty liver treatment, traditional Chinese and western medicine there is no significant drug effect, the main use of lipid regulating drugs as adjuvant therapy. Chinese medicine and the treatment of this disease has its unique advantages, in recent years in theoretical research and clinical research have made great achievements.To "Shugan cholagogic, antipyretic and purgative" for the law, by clinical observation proved to be non-alcoholic fatty liver has obvious therapeutic effects. Clinical observation of the subjects selected standards in line with 60 patients, one of the treatment group 30 cases, 30 cases of the control group, in the conventional treatment, based on the application of Dongbao Gantai (from Shanghai and the Yellow Medicine Co., Ltd. to provide) as a control drug. One course of treatment for 4 weeks. Observation of clinical trial results showed that: The total effective rate was 86.67 percent, significant progress rate of 20%, control group, the total effective rate was 73.3%, significantly progress rate of 3.3%. After statistical treatment, a significant efficiency of the two groups, the total effective rate were significantly different (P <0.05), note the treatment group than the control group.To sum up, Danning tablet treatment of non-alcoholic fatty liver has a better effect, and without any side effects, with the development of the value of depth.